Related Tags >> FDA Clinical Trial FDA approval pharmaceuticals

FDA regulation News

Most Popular FDA regulation Story

Report: FDA readies release of long-awaited rules on biosimilars

September 26, 2011 — 8:44am ET | By John Carroll

Despite increasingly loud groans from the payer community in healthcare, the FDA has demonstrated repeatedly that it plans to take its time to craft a regulatory pathway for biosimilars. Its current Read more...

FDA regulation Press Releases

California Healthcare Institute Board Elects New Member
Research and Markets: Cost-Contained Regulatory Compliance: For the Pharmaceutical, Biologics, and Medical Device Industri
FDA Takes Actions on Darvon, Other Pain Medications Containing Propoxyphene
FDA: Boxed Warning on Serious Mental Health Events to be Required for Chantix and Zyban
Merck Statement in Response to FDA's June Communication with Updated Information on Leukotriene Inhibitors, Including Singulair

Latest Headlines

Report: FDA readies release of long-awaited rules on biosimilars
September 26, 2011
Is the FDA writing a recipe for the failure of biosimilars in the U.S.?
August 8, 2011
FDA proposes companion Dx guidelines
July 13, 2011
FDA outlines steep hurdles, early fees for first-gen biosimilars
May 10, 2011
FDA offers new guidelines to speed combo drug programs
December 15, 2010
FDA wants more details on panel members' potential conflicts
April 22, 2010
Dynavax shares soar as FDA clears hep B trial
September 9, 2009
Protalix gets fast track for its red-hot Gaucher drug
August 25, 2009
J&J development unit slapped with FDA warning letter
August 19, 2009
Geron's pioneering ESC trial put on hold (again)
August 19, 2009
FDA opens up access to experimental meds
August 13, 2009
Aastrom shares jump as FDA lifts clinical hold
June 18, 2009
FDA OKs emergency drug use to combat flu outbreak
April 28, 2009
Developers ready blockbuster diabetes drugs for review
March 27, 2009
Insmed drug OK'd for ALS patients, new trial
March 11, 2009
Takeda down 13 percent on drug delay concerns
March 9, 2009
FDA erred in excluding expert from review
February 24, 2009
Report outlines FDA disregard for trial conflicts
January 12, 2009
FDA: Embeda could carry abuse risk
November 13, 2008
Deadline clock running on Lilly's next big blockbuster
September 22, 2008

Paid Research Reports

More Research Reports >>

Free Newsletter

Most Popular Stories

Webinars

Hottest Products

Featured Jobs

Events